MEK inhibitor
MEK inhibitor is a type of drug that inhibits the mitogen-activated protein kinase kinase (MEK). It is used in the treatment of various types of cancer, including melanoma, lung cancer, colorectal cancer, and thyroid cancer.
Mechanism of action[edit]
MEK inhibitors work by blocking the action of a protein called MEK, which is part of a pathway that helps cells to divide and survive. By inhibiting MEK, these drugs can stop cancer cells from growing and dividing.
Types of MEK inhibitors[edit]
There are several types of MEK inhibitors, including:
Each of these drugs has been approved by the Food and Drug Administration (FDA) for use in certain types of cancer.
Side effects[edit]
Like all drugs, MEK inhibitors can cause side effects. These can vary from person to person, but may include:
See also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
